Iovance Biotherapeutics, Inc. Common Stock (IOVA) is a publicly traded Healthcare sector company. As of May 21, 2026, IOVA trades at $3.55 with a market cap of $1.51B and a P/E ratio of -1.86. IOVA moved +2.02% today. Year to date, IOVA is +44.49%; over the trailing twelve months it is +85.34%. Its 52-week range spans $1.64 to $12.51. Analyst consensus is buy with an average price target of $8.44. Rallies surfaces IOVA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Iovance Biotherapeutics, Inc. Common Stock (IOVA) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. IOVA moved +2.02% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $3.55 |
| Market Cap | $1.51B |
| P/E Ratio | -1.86 |
| EPS | $-1.89 |
| Dividend Yield | 0.00% |
| 52-Week High | $12.51 |
| 52-Week Low | $1.64 |
| Volume | 7.68M |
| Avg Volume | 0 |
| Revenue (TTM) | $1.19M |
| Net Income | $-444.04M |
| Gross Margin | -804.54% |
10 analysts cover IOVA: 0 strong buy, 7 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.44.